Biggest News Aggregation in the World
📰 One Liquid News

One Liquid News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from One Liquid. Real-time updates on events, politics, business and more.

FDA Approves Companion Diagnostics for Encorafenib/Binimetinib in BRAF V600E+ Metastatic NSCLC

The FDA has approved FoundationOne® CDx and FoundationOne Liquid CDx for use as companion diagnostics to identify patients with metastatic non–small cell lung cancer harboring BRAF V600E mutations who may benefit from treatment with the combination of encorafenib plus binimetinib.
Danielle Hicks Foundationone Cdx Encorafenib Braftovi Foundation Medicine Pfizer Inc Foundationone Liquid

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science